| Net income | 65.42M |
| Amortization of investment premiums | 95.14M |
| Depreciation and other amortization | |
| Equity-based compensation costs | 1.24M |
| Amounts related to interest rate swap agreements | 506K |
| Impairment charge related to real estate held for sale | |
| Net change in mortgage securities principal remittance receivable | |
| Net change in remaining receivables, other assets, accounts payable and accrued expenses | |
| Net cash provided by operating activities | |
| Purchases of mortgage securities and similar investments | -2.32B |
| Purchased interest receivable related to purchases of mortgage securities and similar investments | |
| Principal collections on mortgage securities and similar investments | |
| Net cash (used in) provided by investing activities | |
| Proceeds from repurchase arrangements and similar borrowings | 94.43B |
| Principal payments on repurchase arrangements and similar borrowings | -92.33B |
| Decrease (increase) in cash collateral receivable from interest rate swap counterparties | -23M |
| Decrease in cash collateral payable to interest rate swap counterparties | |
| Capital stock transactions | |
| Dividends paid | -83.89M |
| Net cash provided by (used in) financing activities | |
| Net change in cash and cash equivalents | 29.51M |
| Cash and cash equivalents at beginning of period | 54.19M |
| Cash and cash equivalents at end of period | 83.7M |